Cartesian Therapeutics In... (RNAC)
NASDAQ: RNAC
· Real-Time Price · USD
11.23
0.27 (2.46%)
At close: Aug 22, 2025, 3:59 PM
11.23
0.00%
After-hours: Aug 22, 2025, 05:18 PM EDT
Cartesian Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 1.03M | 34.17M | 38.91M | 47.94M | 54.1M | 25.91M | 26M | 34.53M | 48.69M | 82.72M | 110.78M | 123.92M | 127.64M | 108.03M | 85.08M | 67.09M | 47.31M | 27.65M |
Cost of Revenue | 286K | 482K | 665K | 787K | 540K | 970K | 1.4M | 1.89M | 2.39M | 2.26M | 2.29M | 1.68M | 1.14M | 644K | n/a | n/a | n/a | n/a |
Gross Profit | 1.03M | 33.98M | 38.53M | 47.44M | 53.56M | 24.94M | 24.6M | 32.65M | 46.3M | 80.46M | 108.49M | 122.24M | 126.49M | 107.38M | 85.08M | 67.09M | 47.31M | 27.65M |
Operating Income | -88.01M | -52.44M | -43.9M | -53.5M | -48.99M | -81.38M | -86.42M | -58.58M | -47.11M | -14.62M | 14.54M | 27.11M | 26.74M | 13.33M | -4.6M | -16.57M | -28.34M | -45.16M |
Interest Income | 13.72M | 13.17M | 12.32M | 5.87M | 3.3M | 2.1M | 940K | 1.14M | 1.85M | 2.06M | 2.07M | 941K | 242K | 47K | 44K | 35K | 24K | 12K |
Pretax Income | -35.97M | -38.02M | -77.14M | -263.83M | -248.65M | -273.87M | -238.71M | -36.45M | -35.66M | -15.67M | 34.77M | 41.54M | 47.69M | 43.65M | -9.72M | -37.54M | -45.21M | -73.85M |
Net Income | -36.26M | -38.31M | -77.42M | -244.83M | -229.65M | -254.87M | -219.71M | -36.16M | -35.05M | -15.06M | 35.38M | 41.73M | 31.72M | 27.69M | -25.69M | -53.37M | -45.21M | -73.85M |
Selling & General & Admin | 29.2M | 28.99M | 30.13M | 45.21M | 45.26M | 44.34M | 40.58M | 24.13M | 22.75M | 22.38M | 21.57M | 21.07M | 20.67M | 19.1M | 18.93M | 18.47M | 18.07M | 19.54M |
Research & Development | 52.25M | 50.04M | 45.1M | 56.23M | 57.83M | 62.95M | 71.84M | 68.38M | 71.91M | 73.31M | 72.38M | 73.73M | 78.14M | 73.42M | 68.74M | 63.51M | 56.52M | 52.78M |
Other Expenses | 7.58M | 6.87M | 6.39M | -1.46M | -1.65M | -699K | 39K | 311K | 500K | 255K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 89.03M | 85.9M | 81.62M | 99.97M | 101.44M | 106.34M | 111.96M | 92.32M | 94.66M | 95.69M | 93.95M | 94.8M | 98.81M | 92.52M | 87.67M | 81.98M | 74.59M | 72.33M |
Interest Expense | n/a | n/a | n/a | n/a | 1.27M | 2.02M | 2.83M | 3.64M | 3.17M | 3.13M | 3.03M | 2.94M | 2.84M | 2.84M | 2.84M | 2.85M | 2.5M | 1.99M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 89.03M | 86.61M | 82.81M | 101.44M | 103.09M | 107.29M | 112.42M | 93.11M | 95.81M | 97.33M | 96.24M | 96.81M | 100.89M | 94.69M | 89.67M | 83.66M | 75.65M | 72.8M |
Income Tax Expense | 287K | 287K | 287K | -19M | -19M | -19M | -19M | -288K | -609K | -609K | -609K | -183K | 15.97M | 15.97M | 15.97M | 15.83M | n/a | n/a |
Shares Outstanding (Basic) | 25.98M | 25.9M | 25.91M | 21.47M | 16.72M | 5.41M | 5.17M | 5.16M | 5.11M | 5.11M | 4.83M | 5.09M | 4.95M | 4.14M | 3.84M | 3.84M | 3.15M | 3.08M |
Shares Outstanding (Diluted) | 26.45M | 25.9M | 25.91M | 21.47M | 17.79M | 5.41M | 5.17M | 5.16M | 5.11M | 5.11M | 4.83M | 5.09M | 4.95M | 4.14M | 3.84M | 3.84M | 3.37M | 3.08M |
EPS (Basic) | -1.27 | -1.3 | -11.12 | -52.61 | -53.22 | -56.03 | -49.77 | -7.05 | -6.81 | -2.84 | 8.35 | 10.31 | 7.15 | 6.62 | -6.99 | -14.41 | -12.52 | -21.19 |
EPS (Diluted) | -1.28 | -1.34 | -11.16 | -52.65 | -53.26 | -56.03 | -49.77 | -7.05 | -6.86 | -2.89 | 8.12 | 9.92 | 6.81 | 6.20 | -7.23 | -14.49 | -12.6 | -21.19 |
EBITDA | -75.92M | -40.08M | -75.99M | -262.89M | -246.53M | -270.58M | -234.17M | -30.77M | -30.1M | -10.28M | 40.09M | 46.48M | 52.62M | 48.66M | -4.87M | -32.51M | -40.78M | -70.15M |
EBIT | -40.15M | -42.2M | -77.14M | -263.83M | -247.38M | -271.85M | -235.88M | -32.81M | -32.49M | -12.54M | 37.8M | 44.48M | 50.53M | 46.49M | -6.88M | -34.7M | -42.71M | -71.86M |
Depreciation & Amortization | 2.52M | 2.12M | 1.15M | 937K | 840K | 1.27M | 1.7M | 2.04M | 2.39M | 2.26M | 2.29M | 2M | 2.09M | 2.17M | 2.01M | 1.93M | 1.44M | 982K |